Crossmark

Corrigendum to “Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in A protein kinase A and B/Akt manner’’ [Pharmacol. Rep. 68 (2016) 329–337]

Crossref DOI link: https://doi.org/10.1016/j.pharep.2019.05.019

Published Print: 2019-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Bułdak, Łukasz

Machnik, Grzegorz

Bułdak, Rafał Jakub

Łabuzek, Krzysztof

Bołdys, Aleksandra

Belowski, Dariusz

Basiak, Marcin

Okopień, Bogusław
License Information

Text and Data Mining valid from 2019-10-01
More Information

This article is maintained by: Elsevier

Article Title: Corrigendum to “Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in A protein kinase A and B/Akt manner’’ [Pharmacol. Rep. 68 (2016) 329–337]

Journal Title: Pharmacological Reports

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pharep.2019.05.019

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.pharep.2015.10.008

Content Type: simple-article

Copyright: © 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.

Document is current

Any future updates will be listed below